SMSNA Young Clinicians Research Grant
Submission for the 2022 Young Clinicians Research Grant will open on December 1, 2021.
Submission deadline is January 24, 2022.
The award term is July 1, 2022 through June 30, 2023
The maximum award amount is $25,000.
The purpose of the research award program is to support early career investigators in pursuing clinical and/or basic research in men’s or women’s sexual health. The funding is intended to supplement research activities and conference participation to present those activities.
- Applicants should be faculty, in their first three years after either residency or fellowship training, whose practice has a significant focus on sexual medicine. Current residents or fellows are not eligible for this award unless they have a confirmed faculty position during the research grant award term indicated above.
- Applications will be accepted only from SMSNA members in good standing.
- Proof of institutional support for salaries and benefits should be provided at the time of application (letter from Department Chair, Dean, or Designated Institutional Officer).
- For MD’s, a medical license valid in the United States or Canada and proof of satisfactory completion of residency training are required.
- For all human research, IRB number and approval must be documented. Pre-clinical animal research should be reviewed and approved by the ACAR at funding institution.
- Allowable expenses include research supplies, statistical consultation, and logistical support for the assessment and care of research subjects or animals. All awards must be used for the direct expenses of the program and may not be used to cover a salary for a position or activities that bill patient services. Funds may be used to cover direct expenses related to presenting the research. Overhead expenses are not allowable.
- Awards will be paid to the sponsoring institution (medical school, hospital, university). Awards will not be paid directly to the successful applicant or mentor. Funds will be payable in two annual installments available for distribution on or about July 1 of the grant year and January 1 of the following year. The SMSNA does not withhold taxes from the stipends (i.e., federal withholding, social security, local or state taxes, etc.) It is the responsibility of the recipient to ensure that appropriate federal and local taxes are accounted for.
Applicants must complete the online submission form by January 24, 2022 at 11:59 pm CST.
Applications will require the following attachments:
- Bio sketch (1000-word limit)
- Career plan (500-word limit)
- Research abstract (300-word limit)
- Detailed description of research (2000-word limit) divided into four sections:
- Specific aims of the research
- Background of the problem being addressed
- Preliminary research data
- Outline of proposed investigation, including potential alternatives and problems that may be confronted
- Budget, including documentation regarding other available funds (if any) supporting the proposed project
- Letter of support from an SMSNA member
- Applications are reviewed by the Research and Awards Committee and funding must be approved by the SMSNA Board of Directors.
- Funding decisions are based primarily on the merit of the proposed study, applicant and mentor credentials, and the feasibility of the proposed study.
- The recipient will be required to provide both a Mid-term Report and a Final Progress Report. The Mid-term Report is due on or before December 1, 2022. The Final Progress Report is due within 30 days of the end of the award term.
- Recipient will be required to submit an abstract based on their research to the SMSNA Annual Fall Scientific Meeting, following the award term. All accepted abstracts are published in a special edition of the Journal of Sexual Medicine.
Nannan Thirumavalavan, MD
University Hospitals Cleveland Medical Center
Interplay Between Hypogonadism and Solid Organ Transplant Outcomes
Petar Bajic, MD
Glickman Urological and Kidney Institute - Cleveland Clinic
Microbial Composition of Penile Prosthesis Biofilms: Metagenomic Sequencing Analysis